Pantai Premier Pathology (PPP) celebrated its 25th anniversary on 21 December 2022, with an appreciation dinner for staff and partners attended by IHH Chairman Tan Sri Mohammed Azlan and IHH Managing Director & CEO Dr Kelvin Loh.
Additionally, PPP recently announced two new collaborations with bioMérieux and MiRXES to strengthen our lab diagnostics capabilities.
Under the MOU with French biotech MNC bioMérieux, PPP will set up an Antimicrobial Stewardship Centre of Excellence to promote the responsible use of antibiotics and preserve the efficacy of these drugs for the present and future generations. PPP plays a crucial role in supporting the efforts to contain antimicrobial resistance by identifying the pathogen responsible for a patient's infection and conducting antimicrobial susceptibility testing to determine the optimal antimicrobial therapy for the patient.
The collaboration with MiRXES seeks to provide accessible and affordable molecular oncology testing to Malaysians which includes the early detection of gastric cancer via blood test and DNA testing.
These partnerships are critical towards providing our patients with the best care and clinical outcomes. We look forward to further serving our communities through these partnerships.
Congratulations to the PPP team on its Silver Jubilee and the two MOUs!
Related Stories
People-led Innovation Driving Impact Across IHH Healthcare
Gleneagles Hospital Hong Kong Highlights Healthcare at ITB China 2026
Travel today is no longer defined by destinations alone — it is shaped by the confidence and assurance travellers carry with them.
IHH Malaysia Strengthens Care Integration Through GP–Specialist Collaboration
A referral is more than an appointment with another doctor, it is an act of trust.
Parkway MediCentre Xintiandi Launches Integrated Chinese and Western Medicine Health Management Services
Themed "Echoes of the World, Pulse of China", Parkway MediCentre Xintiandi showcased the role of Traditional Chinese Medicine (TCM) through an integrated healthcare approach.
Fortis Memorial Research Institute (FMRI) Launches India's First Centre of Excellence for Myeloma and Lymphoma
Officiated on 11 June, the FMRI Centre of Excellence, brings a highly specialised, patient‑centred and research‑driven approach to managing blood cancers.
Gleneagles Hospital Hong Kong Delivers Seamless Musculoskeletal Care
Gleneagles Hospital Hong Kong is strengthening musculoskeletal (MSK) care through closer collaboration, bringing together insurers and healthcare providers to support a more connected and patient-centred treatment journey.
